Transforming growth factor β1 (TGF-β1) induces Ca2+ entry likely via TRPC1 and NCX1 that raise cytosolic Ca2+ in pancreatic cancer cells so that knockdown of TRPC1 reverses TGF-β1-induced pancreatic cancer cell motility [36]. This evidence concerns the gene TRPC1 and pancreatic neoplasm.